News
Background Progressive supranuclear palsy and Parkinson's disease have characteristic clinical and neuropathologic profiles, but also share overlapping clinical features. This study aimed to ...
FNP-223 is currently being investigated in a phase 2 trial evaluating the treatment in adults with possible or probable PSP-Richardson syndrome.
Find all the latest on progressive supranuclear palsy at Medical Xpress. Your go-to source for news, research, and medical breakthroughs.
Progressive Supranuclear Palsy Phase 2 Platform Clinical Trial Announces the Selection of AADvac1 and AZP2006 for its First Two Regimens ACCESS Newswire. April 28, 2025 9:05 AM.
Progressive Supranuclear Palsy Phase 2 Platform Clinical Trial Announces the Selection of AADvac1 and AZP2006 for its First Two Regimens ACCESS Newswire. April 28, 2025 10:05 AM.
Progressive Supranuclear Palsy Phase 2 Platform Clinical Trial Announces the Selection of AADvac1 and AZP2006 for its First Two Regimens ACCESS Newswire. April 28, 2025 7:05 AM.
Progressive Supranuclear Palsy Phase 2 Platform Clinical Trial Announces the Selection of AADvac1 and AZP2006 for its First Two Regimens ACCESS Newswire. April 28, 2025 10:05 AM.
Progressive Supranuclear Palsy Phase 2 Platform Clinical Trial Announces the Selection of AADvac1 and AZP2006 for its First Two Regimens ACCESS Newswire. April 28, 2025 10:05 AM.
Progressive Supranuclear Palsy Phase 2 Platform Clinical Trial Announces the Selection of AADvac1 and AZP2006 for its First Two Regimens ACCESS Newswire. April 28, 2025 10:05 AM.
Progressive Supranuclear Palsy Phase 2 Platform Clinical Trial Announces the Selection of AADvac1 and AZP2006 for its First Two Regimens ACCESS Newswire. April 28, 2025 10:05 AM.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback